The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment
Open Access
- 23 January 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Human Genetics
- Vol. 16 (5), 603-613
- https://doi.org/10.1038/sj.ejhg.5202003
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Interactions between the adducin 2gene and antihypertensive drug therapies in determining blood pressure in people with hypertensionBMC Medical Genetics, 2007
- Epistatic effect of plasminogen activator inhibitor 1 and β‐Fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: Interaction with environmental/clinical factorsArthritis & Rheumatism, 2007
- Familial DyslipidaemiasDrugs, 2006
- Pharmacogenetics in drug regulation: promise, potential and pitfallsPhilosophical Transactions B, 2005
- Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery diseaseJournal of the American College of Cardiology, 2005
- Classification of gene microarrays by penalized logistic regressionBiostatistics, 2004
- Cross-Validation MethodsJournal of Mathematical Psychology, 2000
- Apolipoprotein E and Complement C3 Polymorphism and Their Role in the Response to Gemfibrozil and Low Fat Low Cholesterol Therapycclm, 1995
- Applied Regression Analysis and Other Multivariate Methods.Journal of the American Statistical Association, 1989
- Effect of cigarette smoking on lipids, lipoproteins, blood coagulation, fibrinolysis and cellular components of human bloodAtherosclerosis, 1975